Inogen (STU:6IO) ROCE % : -20.70% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Inogen ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Inogen's annualized ROCE % for the quarter that ended in Dec. 2024 was -20.70%.

Inogen ROCE % Historical Data

The historical data trend for Inogen's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inogen ROCE % Chart

Inogen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-2.86

2.30

-8.93

-25.35

-18.36

Inogen Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-42.68	-26.32	-11.87	-13.05	-20.70

Inogen ROCE % Calculation

Inogen's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-40.603	/	( ( (299.12 - 66.479)	+	(282.857 - 73.235) )	/ 2 )
	=	-40.603	/	( (232.641	+	209.622)	/ 2 )
	=	-40.603	/	221.1315
	=	-18.36 %

Inogen's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-43.496	/	( ( (275.861 - 65.229)	+	(282.857 - 73.235) )	/ 2 )
	=	-43.496	/	( ( 210.632	+	209.622 )	/ 2 )
	=	-43.496	/	210.127
	=	-20.70 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Inogen (STU:6IO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Inogen ROCE % Related Terms

Thank you for viewing the detailed overview of Inogen's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Inogen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inogen Inc (STU:6IO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

INGN:USA

Address

859 Ward Drive, Goleta, CA, USA, 93111

Website

https://www.inogen.com

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Inogen Headlines

No Headlines